Open channels: Do new cystic-fibrosis therapies hold the key to treating other genetic disorders?
Groopman
Jerome
J
Harvard Medical School.
D002874:Chromosome Mapping / Q000191:economics / Q000266:history / Q000379:methods* / Q000706:statistics & numerical data / Q000639:trends; D002986:Clinical Trials as Topic / Q000266:history / Q000706:statistics & numerical data / Q000639:trends; D003550:Cystic Fibrosis / Q000145:classification / Q000188:drug therapy* / Q000201:enzymology / Q000209:etiology / Q000235:genetics* / Q000266:history* / Q000378:metabolism / Q000401:mortality / Q000473:pathology / Q000534:rehabilitation / Q000628:therapy; D004345:Drug Industry / Q000266:history / Q000379:methods / Q000639:trends; D004358:Drug Therapy / Q000266:history / Q000706:statistics & numerical data / Q000639:trends; D015316:Genetic Therapy / Q000266:history* / Q000379:methods / Q000706:statistics & numerical data / Q000639:trends*; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans